Method for treating immune complex diseases with n-acetylneuraminic acid
US5177062A · kind A · utility
7Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 1989 |
| Grant date | Jan 5, 1993 |
| Priority date | — |
| Expiry date | Mar 20, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A preparation for treating immune complex diseases which comprises injection containing the following compound: ##STR1## wherein when n is 1, Z represents a hydrogen, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, as an active ingredient and pharmacologically acceptable carrier. The preparation of the present invention may be used in any administration method such as hypodermic, intramuscular and intravenous.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.